Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study…
NEW YORK (Reuters Health) – For prevention of contrast-induced nephropathy (CIN), volume supplementation with sodium chloride 0.9% for 24 hours was more effective than a 7-hour regimen of…
NEW YORK (Reuters Health) – Fenofibrate is safe to use in patients with type 2 diabetes and moderate renal impairment, researchers conclude in a report online December 30…
NEW YORK (Reuters Health) – Percutaneous nephrolithotomy (PCNL) can be safely undertaken in patients with chronic kidney disease (CKD), researchers from Turkey report in the November 17th online…
NEW YORK (Reuters Health) – Treatment with the angiotensin receptor blocker (ARB) candesartan is not associated with either carcinogenesis or cancer death compared with non-ARB standard antihypertensive treatment,…
NEW YORK (Reuters Health) – Patients undergoing hemodialysis with a dialyzer that’s sterilized by electron beam have an increased risk of thrombocytopenia, a Canadian study has shown.“Because we…
NEW YORK (Reuters Health) – Laparoscopic partial nephrectomy (LPN) and laparoscopic cryoablation (LCA) are viable nephron-sparing options for patients with a small tumor in a solitary kidney, researchers…
NEW YORK (Reuters Health) – New research supports current clinical guidance to perform partial nephrectomy (PN) when possible in patients with clinically organ-confined renal cell tumors 7 centimeters…
NEW YORK (Reuters Health) – Administering acetylcysteine to patients before and after they undergo coronary or peripheral angiography does not reduce the occurrence of contrast-induced nephropathy, according to…
NEW YORK (Reuters Health) – Beta-blockers improve all-cause mortality in patients with chronic kidney disease (CKD) and heart failure, according to a report in the September 6th Journal…
